Myricetin inhibits Akt survival signaling and induces bad-mediated apoptosis in a low dose ultraviolet (UV)-B-irradiated hacat human immortalized keratinocytes

Journal of Radiation Research

Volumn 51, Issue 3, 2010, Pages 285-296

  Kim, Wanyeon ^a   Yang, Jung Hee ^a   Youn, HyeSook ^b   Yun, Young Ju ^a   Seong, Ki Moon ^c   Youn, Buhyun ^a  

^a Pusan National University   (South Korea)

^b Sejong University   (South Korea)

^c Korea Hydro & Nuclear Power Co   (South Korea)

Author keywords

Akt; Apoptosis; Myricetin; Skin carcinogenesis; UV

Indexed keywords

CELL MEMBRANES; DISEASES; FLAVONOIDS; MITOCHONDRIA; PATHOLOGY; PHOSPHORYLATION; PROTEINS; RADIATION EFFECTS;

AKT; APOPTOTIC PROTEINS; CELL SURVIVAL; INDUCED APOPTOSIS; KERATINOCYTES; LOW DOSE; MYRICETIN; SKIN CARCINOGENESIS; ULTRAVIOLET; ULTRAVIOLET-B;

CELL DEATH;

ANTINEOPLASTIC AGENT; BAD PROTEIN, HUMAN; FLAVONOID; MYRICETIN; PROTEIN 14 3 3; PROTEIN BAD; PROTEIN KINASE B;

ANIMAL; APOPTOSIS; CELL SURVIVAL; CYTOLOGY; HUMAN; KERATINOCYTE; METABOLISM; MITOCHONDRION; MOUSE; SKIN TUMOR; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

14-3-3 PROTEINS; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; FLAVONOIDS; HUMANS; KERATINOCYTES; MICE; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-AKT; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 77953963632     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.09141     Document Type: Article

References (52)

1. Rass K and Reichrath J (2008) UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol 624: 162-178.
2. Staberg B, et al (1983) The carcinogenic effect of UVA irradiation. J Invest Dermatol 81: 517-519.
3. Huang C, et al (1999) P38 kinase mediates UV-induced phos-phorylation of p53 protein at serine 389. J Biol Chem 274: 12229-12235.
4. Peterson J and Dwyer J (1998) Taxonomic classification helps identify flavonoid-containing foods on a semiquantitative food frequency questionnaire. J Am Diet Assoc 98: 677-682, 685; quiz 683-684.
5. Middleton E Jr., Kandaswami C and Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
6. Williams RJ, Spencer JP and Rice-Evans C (2004) Fla-vonoids: antioxidants or signalling molecules? Free Radic Biol Med 36: 838-849.
7. Ko CH, et al (2005) Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. Biochem Pharmacol 69: 913-927.
8. Liu FT, et al (2008) Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood 112: 3835-3846.
9. Ong KC and Khoo HE (1997) Biological effects of myricetin. Gen Pharmacol 29: 121-126.
10. Ichimatsu D, et al (2007) Structure-activity relationship of fla-vonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells. Mol Carcinog 46: 436-445.
11. Lee KW, et al (2007) Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis 28: 1918-1927.
12. Kumamoto T, Fujii M and Hou DX (2009) Akt is a direct target for myricetin to inhibit cell transformation. Mol Cell Biochem 332: 33-41.
13. Kumamoto T, Fujii M and Hou DX (2009) Myricetin directly targets JAK1 to inhibit cell transformation. Cancer Lett 275: 17-26.
14. Jung SK, et al (2008) Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res 68: 6021-6029.
15. Kim JE, et al (2009) MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin. Biochem Pharmacol 77: 412-421.
16. Ichihashi M, et al (2003) UV-induced skin damage. Toxicology 189: 21-39.
17. Wang E, Marcotte R and Petroulakis E (1999) Signaling pathway for apoptosis: a racetrack for life or death. J Cell Biochem Suppl 32-33: 95-102.
18. Jung F, et al (2000) Growth factor-induced phosphoinositide 3-OH kinase/Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc Res 48: 148-157.
19. Goswami R, et al (1999) Overexpression of Akt (protein kinase B) confers protection against apoptosis and prevents formation of ceramide in response to pro-apoptotic stimuli. J Neurosci Res 57: 884-893.
20. Datta SR, et al (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241.
21. del Peso L, et al (1997) Interleukin-3-induced phosphoryla-tion of BAD through the protein kinase Akt. Science 278: 687-689.
22. Brunet A, et al (1999) Akt promotes cell survival by phospho-rylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
23. Fujita E, et al (1999) Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. Biochem Biophys Res Commun 264: 550-555.
24. Ozes ON, et al (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
25. Pastorino JG, Tafani M and Farber JL (1999) Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway. J Biol Chem 274: 19411-19416.
26. Dijkers PF, et al (2002) FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochon-drial integrity. J Cell Biol 156: 531-542.
27. Huang DC and Strasser A (2000) BH3-Only proteins-essential initiators of apoptotic cell death. Cell 103: 839-842.
28. Zha J, et al (1997) BH3 domain of BAD is required for het-erodimerization with BCL-XL and pro-apoptotic activity. J Biol Chem 272: 24101-24104.
29. Kelekar A, et al (1997) Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol Cell Biol 17: 7040-7046.
30. Kluck RM, et al (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
31. Lorenzo HK, et al (1999) Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 6: 516-524.
32. Du C, et al (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42.
33. Boukamp P, et al (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771.
34. Vayssiere JL, et al (1987) Changes in the beta-subunit of mitochondrial F1 ATPase during neurogenesis. Biochem Bio-phys Res Commun 145: 443-452.
35. Wiseman T, et al (1989) Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 179: 131-137.
36. Yang E, et al (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291.
37. Downward J (1999) How BAD phosphorylation is good for survival. Nat Cell Biol 1: E33-E35.
38. Salvioli S, et al (2000) Mitochondrial heterogeneity during staurosporine-induced apoptosis in HL60 cells: analysis at the single cell and single organelle level. Cytometry 40: 189-197.
39. Saleh A, et al (1999) Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem 274: 17941-17945.
40. Daugas E, et al (2000) Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14: 729-739.
41. Murahashi H, et al (2003) Possible contribution of apoptosis-inducing factor (AIF) and reactive oxygen species (ROS) to UVB-induced caspase-independent cell death in the T cell line Jurkat. J Leukoc Biol 73: 399-406.
42. Takasawa R, et al (2005) Differential apoptotic pathways in human keratinocyte HaCaT cells exposed to UVB and UVC. Apoptosis 10: 1121-1130.
43. Kulms D and Schwarz T (2000) Molecular mechanisms of UV-induced apoptosis. Photodermatol Photoimmunol Pho-tomed 16: 195-201.
44. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
45. Kumamoto T, Fujii M and Hou DX (2009) Akt is a direct target for myricetin to inhibit cell transformation. Mol Cell Biochem 332: 33-41.
46. Fresno Vara JA, et al (2004) PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193-204.
47. Shukla S, et al (2005) Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 64: 224-239.
48. Chinni SR and Sarkar FH (2002) Akt inactivation is a key event in indole-3-carbinol-induced apoptosis in PC-3 cells. Clin Cancer Res 8: 1228-1236.
49. Kim AH, et al (2001) Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901.
50. Ichijo H, et al (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94.
51. Magal SS, et al (1998) Induction of apoptosis in human kera-tinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. Int J Cancer 75: 96-104.
52. Wenczl E, et al (1997) Physiological doses of ultraviolet irradiation induce DNA strand breaks in cultured human melano-cytes, as detected by means of an immunochemical assay. Photochem Photobiol 66: 826-830.